CATALOGO DEI PRODOTTI DELLA RICERCA

VICENTINI, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.382
NA - Nord America 1.317
AS - Asia 752
AF - Africa 7
OC - Oceania 6
SA - Sud America 3
Totale 3.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.309
CN - Cina 524
GB - Regno Unito 459
IT - Italia 223
SG - Singapore 155
IE - Irlanda 131
SE - Svezia 131
RU - Federazione Russa 114
DE - Germania 106
FR - Francia 101
FI - Finlandia 57
UA - Ucraina 21
VN - Vietnam 19
BE - Belgio 16
KR - Corea 10
AT - Austria 8
JP - Giappone 8
AU - Australia 6
CA - Canada 6
ID - Indonesia 5
IN - India 5
IR - Iran 5
CZ - Repubblica Ceca 4
MA - Marocco 4
TR - Turchia 4
HK - Hong Kong 3
KG - Kirghizistan 3
NL - Olanda 3
TG - Togo 3
CL - Cile 2
ES - Italia 2
MY - Malesia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
IL - Israele 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
Totale 3.467
Salva come PNG Salva come JPEG
Città #
Southend 440
Chandler 319
Singapore 129
Dublin 122
Beijing 117
Verona 116
Woodbridge 112
Ann Arbor 89
Ashburn 79
Jacksonville 78
New York 55
Shenyang 47
Houston 46
Lawrence 40
Princeton 40
Jinan 38
Wilmington 34
Dearborn 32
Hebei 24
Nanjing 24
Redmond 23
Helsinki 21
Changsha 20
Nanchang 18
Ningbo 18
Zhengzhou 18
Tianjin 17
Brussels 16
Guangzhou 13
Hangzhou 13
Sindelfingen 13
Haikou 12
Taiyuan 12
Seoul 10
Bologna 9
Jiaxing 9
Milan 9
Munich 9
Tokyo 8
Vienna 8
Dong Ket 7
Norwalk 7
Taizhou 7
Kent 6
Redwood City 6
Santa Clara 6
Seattle 6
Washington 6
Fuzhou 5
Jakarta 5
Moscow 5
Chicago 4
Lanzhou 4
London 4
Rome 4
Trevenzuolo 4
Andover 3
Bishkek 3
Boardman 3
Brno 3
Chions 3
Hong Kong 3
Lancaster 3
Lappeenranta 3
Lomé 3
Melbourne 3
Menlo Park 3
Newark 3
Quarto D'altino 3
San Francisco 3
Toronto 3
Bottrop 2
Castelnuovo 2
Cerea 2
Chiayi City 2
Dallas 2
Des Moines 2
Essen 2
Falls Church 2
Frankfurt am Main 2
Gainesville 2
Los Angeles 2
Modugno 2
Nuremberg 2
Padova 2
Qingdao 2
Rabat 2
Roverbella 2
Sacramento 2
San Diego 2
Sossano 2
Tashkent 2
Trieste 2
Winnipeg 2
Yicheng 2
Zanjan 2
Amsterdam 1
Augusta 1
Azzano Decimo 1
Baku 1
Totale 2.442
Salva come PNG Salva come JPEG
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 174
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 158
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 127
Reporting tumor molecular heterogeneity in histopathological diagnosis 126
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 120
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 113
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 110
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 106
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 105
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 104
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 99
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 95
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 90
Fhit down-regulation is an early event in pancreatic carcinogenesis 88
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 88
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 88
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 87
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 83
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 82
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 80
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 79
Exosomal miRNA signatures of pancreatic lesions 77
Comparative Lesions Analysis Through a Targeted Sequencing Approach 75
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer 74
A differentially expressed set of micrornas in cerebro-spinal fluid (CSF) can diagnose CNS malignancies 74
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 74
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 72
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 70
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 68
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 67
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 63
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 63
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 59
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 54
miR-15b/16-2 deletion promotes B-cell malignancies 53
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 53
Current role of non-coding RNAs in the clinical setting 49
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 49
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 47
MCL1 as putative target in pancreatoblastoma 47
Loss of FGFR4 promotes the malignant phenotype of PDAC 46
Lamc2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth 40
Long-term organoid culture of a small intestinal neuroendocrine tumor 37
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 27
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 14
Totale 3.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.059
article - articoli 13.064
book - libri 0
conference - conferenze 995
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 0 0 0 0 0 0 71 39 29 44 61 43
2020/2021337 63 65 20 47 35 26 6 2 8 11 32 22
2021/2022424 31 136 8 38 10 7 5 28 28 7 36 90
2022/2023849 44 117 70 138 83 196 15 45 101 11 10 19
2023/2024406 18 25 39 29 57 88 19 31 5 27 52 16
2024/2025400 52 45 45 160 39 43 16 0 0 0 0 0
Totale 3.554